-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

503.O2.6 503. Clonal Hematopoiesis, Aging, and Inflammation: Mechanisms of Hematopoietic Aging and Inflammation

Symposia: Clonal Hematopoiesis, Aging, and Inflammation Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acquired Marrow Failure Syndromes, CHIP, Translational Research, Bone Marrow Failure Syndromes, Genetic Disorders, Hematopoiesis, Immune mechanism, Diseases, Immune Disorders, Immunology, Metabolism, Biological Processes, Myeloid Malignancies, Molecular biology, Multi-systemic interactions, Pathogenesis
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Grand Hall D (Manchester Grand Hyatt San Diego)
Moderators:
Gregor Hoermann, MD, PhD, MLL Munich Leukemia Laboratory and Lambert Busque, MD, Maisonneuve-Rosemont Hospital
Disclosures:
Hoermann: Blueprint Medicines: Membership on an entity's Board of Directors or advisory committees; AstraZeneca: Honoraria; Gilead: Membership on an entity's Board of Directors or advisory committees; Jazz Pharmaceuticals: Membership on an entity's Board of Directors or advisory committees; Cogent: Membership on an entity's Board of Directors or advisory committees. Busque: Novartis: Consultancy, Honoraria; GSK: Consultancy.
2:00 PM

Samuel J Magaziner, MPhil1, Jason C Collins, PhD2*, Brecca Miller1,3*, Kelly V Ruggles, PhD3*, Achim Werner, PhD2* and David B Beck, MD, PhD1*

1Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY
2Stem Cell Biochemistry Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD
3Institute for Systems Genetics, NYU Grossman School of Medicine, New York, NY

2:15 PM

Justin CT Loke, MD PhD1,2, Geon Kim, MD1*, Meaghan Boileau, PhD3*, Thuy T.P. Nguyen, PhD4*, Marie E McConkey, PhD1*, Aidan P. Miller, BSc1*, Wesley Shin1*, Christopher B. Hergott, MD, PhD1,5*, Maria Ericsson, PhD6*, Anja E.H. Nordstrom6*, Scott A Armstrong, MD, PhD3, Joseph D Mancias, MD PhD4* and Benjamin Levine Ebert, MD, PhD1,7,8

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2University of Birmingham, Birmingham, United Kingdom
3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
4Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
5Department of Pathology, Brigham and Women’s Hospital, Boston, MA
6Department of Cell Biology, Harvard Medical School, Boston, MA
7Broad Institute of MIT and Harvard University, Cambridge, MA
8Howard Hughes Medical Institute, Boston, MA

2:30 PM

Zanshe Thompson, PhD, MS1, Iliana Herrera, BS2*, Zion Williams2*, Li Z Luo, PhD3*, Audrey-Ann Supreme, BS4,5*, Bailey West, BS6*, Hyunsung Woo, MS7*, Marios Arvantis, MD8*, Charles Lowenstein9*, Lewis Becker10* and Linda Resar, MD11

1Division of Hematology, The Johns Hopkins University School of Medicine, Owings Mills, MD
2The Johns Hopkins University School of Medicine, Baltimore
3Department of Medicine, Division of Hematology, The Johns Hopkins University School of Medicine, Baltimore, MD
4Doctoral Diversity Program, Johns Hopkins University School of Medicine, Baltimore, MD
5Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
6Pathobiology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, MD
7The Johns Hopkins University, Baltimore
8Cardiology, The Johns Hopkins University School of Medicine, Baltimore
9The Johns Hopkins University School of Medicine, Baltimore, MD
10Johns Hopkins University School of Medicine, Baltimore, MD
11Division of Hematology, Departments of Medicine, Oncology & Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD

2:45 PM

Ludovica Marando, MD, PhD1, George Giotopoulos, PhD2*, Pedro Madrigal3*, Dhoyazan M A Azazi3*, Ryan Asby3*, Maria Erendira Calleja-Cervantes4*, David Lara-Astiaso3*, Nicola K. Wilson5*, Rebecca Hannah5*, Jaana Bagri3*, Elsa Barnard6*, Sarah J Horton, PhD2*, Berthold Gottgens3, Elli Papaemmanuil7, Shuchi Agrawal Singh3*, Malgorzata Gozdecka3*, George S Vassiliou, MD, PhD3 and Brian J P Huntly, MD3*

1University of Cambridge, Cambridge, United Kingdom
2Cambridge Stem Cell Institute, Cambridge, United Kingdom
3Department of Haematology and Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
4Centro de Investigación Médica Aplicada, University of Navarra, Pamplona, Spain
5Department of Hematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
6Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

3:00 PM

Marco De Dominici, PhD1,2, Lamis Naddaf, PhD3, Vadym Zaberezhnyy4*, Andrew Goodspeed4*, Sheng Li, PhD5* and James Degregori, PhD6

1University of Colorado, Aurora, CO
2University of Colorado Anschuz Medical Campus, Aurora, CO
3USC Keck School of Medicine - University of Southern California, Farmington, CT
4University of Colorado Anschutz Medical Campus, Aurora, CO
5Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, CA
6Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO

3:15 PM

Yujun Dai, MD, PhD1*, Xue-Ping Li2* and Yang Liang3

1Sun Yat-sen University Cancer Center (SYSUCC), Shanghai, China
2Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
3Department of Hematological Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China

*signifies non-member of ASH